Bruce; Marc A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bruce; Marc A..The latest application filed is for "1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto".

Company Profile

0.6.4

Bruce; Marc A. - Escondido CA
Bruce; Marc A. - San Marcos CA
Bruce; Marc A. - Wallingford CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
1,2,3-trisubstituted Aryl And Heteroaryl Derivatives As Modulators Of Metabolism And The Prophylaxis And Treatment Of Disorders Related Thereto App 20110112060 - Jones; Robert M. ; et al.	2011-05-12
Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto Grant 7,838,525 - Jones , et al. November 23, 2	2010-11-23
Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto Grant 7,470,699 - Jones , et al. December 30, 2	2008-12-30
Gpr41 and Modulators Thereof for the Treatment of Insulin-Related Disorders App 20080312277 - Leonard; James N. ; et al.	2008-12-18
Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the phophylaxis and treatment of disorders related thereto App 20070155763 - Jones; Robert M. ; et al.	2007-07-05
Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto App 20050070562 - Jones, Robert M. ; et al.	2005-03-31
NPY antagonists: spiroisoquinolinone derivatives Grant 6,348,472 - Poindexter , et al. February 19, 2	2002-02-19
Dihydropyridine NPY antagonists: cyanoguanidine derivatives Grant 6,001,836 - Poindexter , et al. December 14, 1	1999-12-14
Dihydropyrimidone derivatives as NPY antagonists Grant 5,889,016 - Bruce , et al. March 30, 1	1999-03-30
Ethylamino carbazole melatonergic agents Grant 5,677,328 - Takaki , et al. October 14, 1	1997-10-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.